# Scienture Holdings, Inc.

Scienture Holdings, Inc. is a public company listed on Nasdaq as SCNX, headquartered in Commack, NY, United States.

## Company overview

- **Legal name:** Scienture Holdings, Inc.
- **Former names in filing history:** TRxADE HEALTH, INC (2021-06-02 to 2024-08-28); TRXADE GROUP, INC. (2014-06-11 to 2021-05-28); XCELLINK INTERNATIONAL INC. (2008-11-18 to 2014-01-31); Bluebird Exploration Co. (2007-06-15 to 2008-12-10)
- **Classification:** Public company
- **Industry (SIC):** 2834 — Pharmaceutical Preparations
- **Headquarters:** Commack, NY, United States
- **Incorporated in:** DE
- **Fiscal year end:** December 31
- **Ticker:** Nasdaq: SCNX
- **SEC CIK:** 0001382574

## About

Scienture Holdings, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001382574, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2026-03-30, it reported annual revenue of USD 431,609; net income of USD -41,512,264; total assets of USD 84,178,330 for the fiscal period ended 2025-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2025 (period ended 2025-12-31)

- **Revenue:** $431,609 (USD 431,609)
- **Net income:** -$41.5M (USD -41,512,264)
- **Total assets:** $84.2M (USD 84,178,330)
- **Cash and equivalents:** $6.7M (USD 6,662,008)
- **Operating cash flow:** -$13.4M (USD -13,379,683)
- **Later filings:** Net income: shown as originally filed; later filings report different values for the same periods.

### FY2024 (period ended 2024-12-31)

- **Revenue:** $136,643 (USD 136,643)
- **Net income:** $9.1M (USD 9,065,798)
- **Total assets:** $104.9M (USD 104,853,805)
- **Operating cash flow:** -$14.3M (USD -14,265,239)
- **Later filings:** Net income: shown as originally filed; later filings report different values for the same periods.

### FY2023 (period ended 2023-12-31)

- **Revenue:** $8.3M (USD 8,272,214)
- **Net income:** -$17.8M (USD -17,843,574)
- **Total assets:** $12.5M (USD 12,532,913)
- **Cash and equivalents:** $151,908 (USD 151,908)
- **Later filings:** Revenue, Cash and equivalents: shown as originally filed; later filings report different values for the same periods.

### FY2022 (period ended 2022-12-31)

- **Revenue:** $11.4M (USD 11,448,265)
- **Net income:** -$3.5M (USD -3,472,099)
- **Total assets:** $3.7M (USD 3,710,026)
- **Cash and equivalents:** $1.1M (USD 1,133,633)
- **Operating cash flow:** -$1.5M (USD -1,525,929)
- **Later filings:** Revenue, Cash and equivalents: shown as originally filed; later filings report different values for the same periods.

## Recent SEC filings

- Form 8-K — filed 2026-10-07 — period 2026-10-05 — 8-K
- Form DEF 14A — filed 2026-09-18 — period 2026-09-18 — DEF 14A
- Form 8-K — filed 2026-09-14 — period 2026-09-14 — 8-K
- Form 8-K — filed 2026-08-20 — period 2026-08-14 — 8-K
- Form 10-Q — filed 2026-08-13 — period 2026-06-30 — 10-Q
- Form 8-K — filed 2026-05-29 — period 2026-05-26 — 8-K
- Form 8-K — filed 2026-05-22 — period 2026-05-18 — 8-K
- Form 10-Q — filed 2026-05-15 — period 2026-03-31 — 10-Q
- Form 8-K — filed 2026-05-05 — period 2026-05-05 — 8-K
- Form 8-K — filed 2026-05-01 — period 2026-04-27 — 8-K
- Form 10-K/A — filed 2026-04-30 — period 2025-12-31 — 10-K/A
- Form 10-K — filed 2026-03-30 — period 2025-12-31 — 10-K

---

Updated: 2026-10-23T06:09:42Z

Canonical page: https://altss.com/profile/scienture-holdings-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology